Schroetter Syndrome: Effort-Induced Upper Extremity DVT Explained
Indunil Karunarathna, Founder of Uva Clinical Research Lab (UCRL), posted on LinkedIn:
”Schroetter Syndrome Effort Induced Upper Extremity Deep Vein Thrombosis
Paget-Schroetter syndrome (PSS), also known as “effort thrombosis,” represents a primary form of upper extremity deep vein thrombosis (UEDVT) typically arising in young, healthy, and active individuals following strenuous or repetitive upper limb exertion.
Recognized as the venous subtype of thoracic outlet syndrome (TOS), PSS occurs due to mechanical compression of the subclavian vein within the costoclavicular space, often potentiated by structural anomalies such as cervical ribs, hypertrophied scalene muscles, or aberrant ligamentous insertions. The pathophysiology integrates Virchow’s triad, with endothelial trauma, venous stasis, and hypercoagulability converging to precipitate thrombosis.
Clinically, PSS presents with sudden upper extremity swelling, pain, heaviness, and cyanosis, often following athletic or occupational activity. Diagnosis requires high clinical suspicion and confirmation with duplex ultrasonography, venography, or advanced cross-sectional imaging, while laboratory investigations may identify concomitant thrombophilic disorders.
Management strategies emphasize multimodal therapy: immediate anticoagulation, catheter-directed thrombolysis (CDT) or pharmacomechanical thrombectomy for clot clearance, and surgical thoracic outlet decompression to correct the underlying anatomical cause. Long-term outcomes are optimized by interdisciplinary collaboration involving vascular surgeons, radiologists, internists, and rehabilitation specialists.
Despite advances in endovascular and surgical techniques, controversies remain regarding timing of decompression, duration of anticoagulation, and management of chronic venous occlusion. With appropriate treatment, recanalization rates of 75–90% are achievable, preventing long-term complications such as recurrent thrombosis, pulmonary embolism, and postthrombotic syndrome.
Future research should focus on refining minimally invasive strategies, optimizing patient selection for surgical intervention, and developing preventive approaches for high-risk athletic populations.”
Read the full article here.
Author: Indunil Karunarathna
Stay updated with Hemostasis Today.
-
May 29, 2026, 13:49Tareq Abadl: The Rh Blood Group System – Meet the 5 Antigens That Matter Most
-
May 29, 2026, 13:39Kalyan Roy: Hematopoietic Stem Cell Transplantation in Thalassaemia
-
May 29, 2026, 12:53Wolfgang Miesbach: The Risk of Deskilling in Modern AI Assisted Medicine
-
May 29, 2026, 12:20Pall T. Onundarson: Is Anonymous Peer Review Always Objective
-
May 29, 2026, 11:59Jolene Ng: New Review Explores the Pathophysiology of Pre-Eclampsia
-
May 29, 2026, 11:44Lynne Baird: Why Expanding Bleed Control Kits Across Public Transport Matters
-
May 29, 2026, 11:30Rumbidzai Mushambi: When ‘Just Hormones’ Delays Real Diagnosis
-
May 29, 2026, 09:53Yassin Taher: Recognizing Clonal Eosinophilic Disorders in Pediatric Hypereosinophilic Syndrome
-
May 29, 2026, 09:52Sergio Emanuel Kaiser: Ruvonoflast and a New Anti-Inflammatory Strategy for Residual Cardiovascular Risk